News1 min ago
Serca Pharmaceuticals showcases exciting data on 13-M at Heart Failure 2023
First-in-class, cardioprotective drug with potential to transform treatment following myocardial infarction and stenting OSLO, Norway, May 22, 2023 /PRNewswire/ — Serca Pharmaceuticals, a Cardioprotection company that is...
